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Results
Besides a notably low blood pressure, the
Sherpa participant characteristics were
unremarkable relative to the lowlander
cohort (table 1).
Plasma myostatin was unchanged between
0 and 2 hours (p = 0.338), but significantly
reduced at 4 hours, relative to 0 hours (p =
0.01) and 2 hours (p < 0.01; Figure 2A). This
finding is maintained if results are expressed
relative to baseline (Figure 2B). No
difference is noted between the Sherpa
individual and the lowlander cohort.
Lowlander (n = 8) Sherpa (n = 1)
Age 27.5 (8.1) 26
height (cm) 174.6 (7.7) 160.0
Weight (kg) 76.9 (12.9) 70.3
BMI (kg.m-2) 22.3 (8.7) 27.5









Muscle is the largest tissue in the human
body and the size of muscle is significantly
regulated by the protein myostatin1,2. Chronic
hypoxemia in vivo induces muscle atrophy in
both healthy mountaineers and patients with
COPD (figure 1)3. However, both COPD
patients and mountaineers are difficult
models to study due to several confounding
factors. Chronic hypoxia in mice and COPD
patients co-presents with elevated
myostatin4, suggestive of a causative role.
We previously showed that acute hypoxia
(12 % O2) induced a decrease expression of
myostatin in both muscle and plasma of
otherwise healthy individuals (5-6)
We therefore aimed to determine the effect
of hypoxic dose, hypothesizing that
increasing hypoxic dose would result in
further reductions in myostatin concentration.
Methods
Healthy males (N = 9, 27.5 [8.1] years of
age) visited the laboratory twice, in a fasted
state. Participants gave a venous plasma
sample, were placed in a normobaric
hypoxic chamber (10.7 or 12.3 % O2, blinded,
random order) for 2 hours, with a second
plasma sample taken following hypoxia, and
a 3rd sample 2 hours following hypoxic
exposure (figure 2). During recruitment, one
Sherpa participant, native to the Tibetan
Plateau (4,500 altitude), was identified. This
individual is herein characterized separately.
Acute hypoxia reduces plasma myostatin independent 
of hypoxic dose
SpO2 was reduced during hypoxic exposure,
and this reduction was greater in the 10.7 %
condition compared with the 12.3 %
condition (Figure 3). The Sherpa individual
did not desaturate at 12.3 % O2, but showed
the lowest measured SpO2 at 10.7 % O2.
Discussion
Here we show a decreased concentration of
plasma myostatin following acute hypoxic
exposure in healthy young male participants.
This work aligns with our previous findings,
reduced plasma myostatin after 10 hours of
hypoxia (12 %) and extends this, suggesting
dose of hypoxia (within the range measured
here), does not alter the myostatin response.
Further, differences in the SpO2 desaturation
response are not reflected in the changes in
plasma myostatin.
What physiological meaning can be ascribed
this reduction in myostatin concentration in
plasma? Myostatin acts in an endocrine
manner, systemic concentration correlates
with muscle mass across cachexic and
healthy individuals. However, myostatin
activity is extracellular, binding myofibers
surface receptors to induce an atrophic
signalling cascade. Thus, it is tempting to
speculate decreases in plasma myostatin
may represent a shift towards extracellular
space; this needs to be confirmed by
microdyalysis studies in small animal or
human models. Alternatively, myostatin in
plasma may be degraded or sequestered in
an as yet undescribed manner, as a
protective response against an acute
catabolic insult.
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Figure 2: Healthy males (N = 9) exposed to 2 hours of 10.7 or 12.3
% O2, separated by 7 days. Plasma collected pre, post and 2
hours post exposure.
Figure 1: Both healthy individuals at altitude and hypoxemic COPD
patients lose muscle mass.
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Figure 3: SpO2 as a function of time. Black indicates lowlander
population (n = 8), red indicates Sherpa (N = 1). * indicates difference
between lowlander groups. Error bars represent se.
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Figure 2: A) Absolute myostatin concentration (pg.mL-1) as a function
of time (hours). B) relative myostatin concentration (% of 0 hours) as a
function of time (hours). Black indicates lowlander population (n = 8),
red Sherpa (n = 1). Open circles indicate 10.7 % conditions, closed
squares 12.3 % O2 condition. * indicates differences between groups as




Figure 4: Proposed model of myostatin movement in response to
hypoxic stimulus.
Ambient air (20.9 %)
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